No Data
No Data
Warrant Pharmaceutical's Unit Gets Nod to Trial Psoriasis Drug
Warner Pharmaceutical Factory (688799.SH): ZG-002 tablets have obtained the Notice of Approval for Clinical Trial of Drugs.
Warner Pharmaceutical Factory (688799.SH) announced that its holding subsidiary, Shanghai Zhigen Medical Technology Co., Ltd...
Warner Pharmaceuticals (688799.SH) subsidiary's active pharmaceutical ingredient dimethyl silicone oil has received a notice of approval for market application.
Warner Pharmaceutical Factory (688799.SH) announced that its wholly-owned subsidiary, Hunan Warner Dapuyan Chirality Pharmaceuticals...
Hunan Warrant Pharmaceutical Gets Supplementary Application Approval for Diabetes Medication
Warner Pharmaceuticals (688799.SH): Metformin and glimepiride tablets pass the consistency evaluation of generic drug quality and efficacy.
On July 31st, Gelunhui reported that Warner Pharmaceutical Factory (688799.SH) has received the "Drug Supplementary Application Approval Letter" issued and approved by the National Medical Products Administration for Metformin and Pioglitazone Hydrochloride Tablets. Metformin and Pioglitazone Hydrochloride Tablets are used to improve blood sugar control in type 2 diabetes patients who cannot achieve adequate control with diet and exercise alone.
Hunan Warrant Pharmaceutical Co.,Ltd's (SHSE:688799) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
No Data